Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries
Open Access
- 30 September 2013
- journal article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 58 (3), 682-686
- https://doi.org/10.1016/j.jvs.2013.02.019
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive diseaseJournal of Vascular Surgery, 2011
- Conventional Balloon Angioplasty versus Peripheral Cutting Balloon Angioplasty for Treatment of Femoropopliteal Artery In-Stent Restenosis: Initial ExperienceRadiology, 2008
- Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the LegThe New England Journal of Medicine, 2008
- Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional StentingCirculation, 2007
- A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteriesEuropean Heart Journal, 2007
- Cryoplasty for Arterial RestenosisEuropean Journal of Vascular and Endovascular Surgery, 2007
- Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO TrialJournal of Endovascular Therapy, 2006
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterThe New England Journal of Medicine, 2006
- Long-Term Results After Directional Atherectomy of Femoro-Popliteal LesionsJournal of the American College of Cardiology, 2006